• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsModerna
    Picture of Moderna logo

    MRNA — Moderna News Story

    $236.500.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    • Market Cap
      $94.42bn
    • Enterprise Value
      $89.91bn
    • Revenue
      $1.94bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • MRNA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    MRNA Dividends
    All News

    NASDAQ RESUMED AT 12:39 PM

    Picture of Moderna logoModerna
    Today 17:39
    NASDAQ RESUMED  AT 12:39 PM

    Recent news on Moderna

    See all news
    • Merck/Moderna cancer vaccine cuts risk of melanoma death or recurrence by over 40% (updated)

      Today 20:11
    • Brief: Merck Says Intismeran Plus Keytruda Significantly Reduced Risk Of Recurrence Or Death By 42%

      Today 19:42
    • Merck/Moderna cancer vaccine cuts risk of death or recurrence from melanoma by over 40%

      Today 19:25
    • NASDAQ RESUMED AT 12:39 PM

      Today 17:39
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:34 PM

      Today 17:34

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.